FdaApplication

NDA 020712

Back to search

Identifiers

Properties

PropertyValue
applicant_nameTAKEDA PHARMACEUTICALS USA INC
application_typeNDA
approval_date1997-09-30

Products (3)

ProductActive ingredientStrengthDosage form
CARBATROLCARBAMAZEPINE200MGCAPSULE, EXTENDED RELEASE;ORAL
CARBATROLCARBAMAZEPINE100MGCAPSULE, EXTENDED RELEASE;ORAL
CARBATROLCARBAMAZEPINE300MGCAPSULE, EXTENDED RELEASE;ORAL

3 products